Carl Marks Securities served as financial advisor to Hawkins Point in the sale of the leading life sciences consultancy to Verista, a transformative compliance and automation solutions organization for the life sciences industry. Financial terms of the private transaction were not disclosed.

Founded in 2012 by Heather Morris Kyer and Steve Mersky and based in Boston, Hawkins Point focuses on helping clients solve challenges across the entire life sciences continuum, from early-stage research to full commercial operations and beyond. The firm relies on deep domain expertise and extensive knowledge of frameworks, assets and accelerators to serve clients across the life sciences, pharma, biotech, medical device, and related industries.

“The Carl Marks team brought an intimate understanding of the needs of our founder-owned business as well as a true sense of partnership, which was even more important given the virtual nature of the transaction,” said Morris Kyer, CEO and Co-Founder of Hawkins Point, who has joined the Verista leadership team. “We are so grateful to Chris and his team for their extraordinary guidance during this process, and for helping us find a great firm in Verista.  We are excited for the next phase of our growth and opportunities for our colleagues with this new partner.

“From initial contact with the Hawkins Point team through signing on the dotted line, this entire process was conducted virtually,” said Chris Parisi, Managing Director at Carl Marks Advisors. “I am extremely proud of how our team was able to adapt quickly and efficiently to the environment and create a smooth process for every stakeholder involved. We are confident Verista is the right partner to help Hawkins Point expand its reach and expertise while maintaining the strong culture Heather and Steve have built.”